The huge discovery that Henning Løwenstein and his colleague made in the 1970’s catapulted ALK out of the niches and onto the global market. But now the Danish pharmaceutical company wants to go one step further. It wants to develop a cure that’s less time consuming, less painful and more effective. All for the sake of the patients. Does that sound easy? Well, it isn’t and they need help from a young doctor. This podcast is published by ALK and produced and developed by Rakkerpak ProductionsNarrator: Nadia NouamaniWritten by Mads Gordon LadekarlSound editing and sound mixing: René SlottMusic: Christian Schødts-SørensenEditor: Tor Arnbjørn